Search

Aim to improve the quality of life of patients in the early postoperative period after septoplasty. Material and methods. The study involved patients who underwent septoplasty (n=51). The patients were divided into two groups: in group A (n=26) classic intranasal splints were installed at the end of the operation; in group B (n=25) we used the modified intranasal splints with an integrated rigid duct, with a pressure distributor placed mainly in the anterior nasal septum and the latches along the periphery (patent No. 191163). To assess the patients comfort before and on the first day after surgery, a quality of life assessment questionnaire (Sino-Nasal Outcome Test SNOT-20) was used. The headache intensity was evaluated in the early postoperative period using a visual analog pain scale. Statistical data processing was carried out using the STATISTICA 12 software. Results. According to the results of SNOT-20, we obtained a statistically significant (p 0.05) improvement in the quality of life of patients when using our modified splits against the traditional splits. Comparing the data of the SNOT-20 questionnaire and VAS, we found a statistically significant (p 0.05) reduction in pain in the early postoperative period when using our intranasal splints with an integrated air duct and pressure distributor. Conclusion. The use of our modified intranasal splints improves the quality of life of patients in the early postoperative period.

After septoplasty procedure and removing of nasal packing, numerous symptoms usually appear that result from inflammation., Objective: To evaluate the effect of nasal spray Polydexa with phenylephrine on the postoperative period and bacterial contamination in the nasal cavity after septoplasty and inferior turbinectomy., Material and Methods: There were 40 people observed, who underwent septoplasty and inferior turbinectomy followed by nasal packing., Results: After removing the tampons from the nasal cavity, the growth of coagulase-negative staphylococci was most often observed in 50%, Enterococcus faecalis - 22.5%, Staphylococcus aureus - 20.0%. In patients who received intranasally Polydexa with phenylephrine drug in the postoperative period, we observed decrease in inflammation in the nasal cavity, an improvement in the quality of life, as well as a significant ( p <0.05) decrease in bacterial growth (both in the presence of flora and in intensity growth of microorganisms). The absence of intranasal antibacterial drugs in the scheme of postoperative management of patients contributes to the growth of pathogenic flora, in particular S. aureus .